Atomoxetine Hydrochloride Capsules Market: Expanding Treatment Options for ADHD Management
The Atomoxetine Hydrochloride Capsules Market continues to grow as healthcare providers seek effective non-stimulant alternatives for attention-deficit hyperactivity disorder treatment. As the first non-stimulant medication approved by the FDA specifically for ADHD, atomoxetine offers a distinct mechanism of action as a selective norepinephrine reuptake inhibitor, making it particularly...
0 Commentarii 0 Distribuiri 399 Views 0 previzualizare
social art-inpa https://social.art-inpa.com